Blood test may predict best dose for nerve disorder treatment
Knowledge-focused
Completed
This study looked at 20 adults with chronic nerve conditions (CIDP or MMN) who were starting IVIg treatment. Researchers wanted to see if changes in IgG levels in the blood after the first dose could help predict the best long-term dose for each patient. The goal is to make dosin…
Sponsor: Walton Centre NHS Foundation Trust • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC